We are international
Donate
• treatment options TEXT SIZE   
novel therapies    back

NEW DRUG COMBINATION - VELCADE® PLUS DOXIL® - APPROVED FOR MYELOMA
Combination Provides 43% Improvement in Time to Disease Progression
05.22.07

Be the first to comment

 related articles